http://orcid.org/0000-0003-2419-5909
Figures
Abstract
The increasing resistance to carbapenems is an alarming threat in the fight against multiresistant bacteria. The dissemination properties of antimicrobial resistance genes are supported by their detection in a diverse population of bacteria, including strains isolated from the environment. The objective of this study was to investigate the presence of carbapenemase-producing Enterobacteriaceae (CPE) collected from a river ecosystem in the Barcelona metropolitan area (Spain). Identification of β-lactamases and other resistance determinants was determined as was the antimicrobial susceptibility profile. Moreover, screening of virulence factors, plasmid addiction systems, plasmid partition systems and replicon typing was performed. The results identified 8 isolates belonging to different species (Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Klebsiella oxytoca, Raoultella ornithinolytica). The most prevalent enzyme was KPC-2 (n = 6), followed by VIM-1 (n = 2) and IMI-2 (n = 1), whereas no OXA-48-type was detected. In addition, one strain was positive for both KPC-2 and VIM-1 enzymes. All the carbapenemase-encoding plasmids carried at least one plasmid addiction or partition system, being vagCD and parAB the most frequently detected, respectively. E. coli and K. pneumoniae isolates carried a low number of virulence-associated factors and none of the detected clones has previously been identified in the clinical setting. These findings support the high dissemination potential of the carbapanemase-encoding genes and reinforce the idea that the environment is another reservoir that may play an important role in the capture, selection and dissemination of carbapenem resistance genes.
Citation: Piedra-Carrasco N, Fàbrega A, Calero-Cáceres W, Cornejo-Sánchez T, Brown-Jaque M, Mir-Cros A, et al. (2017) Carbapenemase-producing enterobacteriaceae recovered from a Spanish river ecosystem. PLoS ONE 12(4): e0175246. https://doi.org/10.1371/journal.pone.0175246
Editor: Yung-Fu Chang, Cornell University, UNITED STATES
Received: December 14, 2016; Accepted: March 22, 2017; Published: April 5, 2017
Copyright: © 2017 Piedra-Carrasco et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This study was supported by the Ministerio de Economía y Competitividad (http://www.mineco.gob.es/), Instituto de Salud Carlos III (http://www.isciii.es/), co-financed by the European Regional Development Fund (ERDF) ‘A Way to Achieve Europe’ (http://ec.europa.eu/regional_policy/en/funding/erdf/), the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0003) (http://reipi.org/), and the Spanish Ministry of Health (FIS PI15/00604 to JGL). NPC is financially supported by the REIPI RD12/0015/0003. WC-C is recipient of PhD fellowship SENESCYT 2012 from the Republic of Ecuador Government. MB-J has a grant from COLCIENCIAS (Republic of Colombia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
The current therapeutic options to combat infections caused by the increasingly detected Escherichia coli and Klebsiella pneumoniae clinical isolates resistant to third and/or fourth generation cephalosporins are becoming increasingly fewer [1]. Carbapenems are usually the last resort to fight against these difficult-to-treat infections as, in most cases, these microorganisms also exhibit a multidrug resistance phenotype [2]. Unfortunately, Enterobacteriaceae strains resistant to carbapenems are emerging and compromising the outcome of patients receiving these drugs and posing a serious threat to the health care system [2].
Previous studies have revealed the presence of carbapenemase- and/or extended-spectrum β-lactamase-producing Enterobacteriaceae in samples collected from rivers, effluents and hospital sewage systems [3]. The enzymes detected include KPC, IMI, VIM, IMP, OXA-48-type and NDM, highlighting their carriage in K. pneumoniae and E. coli strains [3]. The presence of these resistant determinants in aquatic environments can be understood according to different scenarios: i) these niches constitute a reservoir of novel carbapenem resistance genes (e.g. KPC-2 homologs have been identified in the genera Chromobacterium, commonly isolated from aquatic environments) [4]; ii) resistant bacteria of human origin are released into the environment hence spreading their resistance genes into environmental species [5]; iii) carbapenemase-producing Enterobacteriaceae (CPE) detected not only in farms but also in companion pets and wild animals, can also reach the environment via manure [3].
Recently there has been great interest in tracing plasmids conferring drug resistance, particularly carbapenem resistance, as a result of the promiscuity of these genes. Their incredible mobilization ability has forced the introduction of accurate surveillance and control measures to hinder their spread, with special effort in the clinical setting. Over the past years plasmid characterization has mainly been based on identification of the plasmid incompatibility group [6]. More recently, however, the study of plasmid addiction systems (PAS), and to a lesser extent, plasmid partition systems (PPS), has gained relevance. These mechanisms ensure stable transmission of plasmids by post-segregational killing of plasmid-free daughter cells and driving plasmid positioning during bacterial division processes. Their role in plasmid maintenance may represent a potential key factor involved in their successful dissemination [7,8].
At present, there are few epidemiologic studies regarding CPE recovered from rivers. Some studies have been conducted in Portugal [9], US [10], Tunisia [11], India [12] and China [13,14], but none in Spain. Moreover, little attention has been directed towards the prevalence of PAS and PPS in carbapenemase-encoding plasmids. The aim of the present study was to explore the presence of CPE in the Llobregat river ecosystem, an important river in the Barcelona metropolitan area which is the most populous metropolitan area in the Mediterranean coast and hence with a high anthropogenic impact and scarce contribution of animal fecal contaminants [15]. Isolates and plasmids harboring these resistance elements were characterized in order to gain new insight into the factors supporting their dissemination worldwide.
Materials and methods
Collection of river samples and selection of carbapenem-resistant Enterobacteriaceae
Eleven sediment and 12 water samples were collected from the Sant Joan Despí station (UTM: 31T 420339 4578455) of the Llobregat river, Catalunya, Spain from May to December, 2014. This river receives anthropogenic impact via secondary effluents of municipal wastewater treatment plants and industrial effluents along the river course in the Barcelona metropolitan area [16] whereas the impact of animal fecal contaminants is very low and irregular [15]. River water was used without further processing while five g of sediment were homogenized in PBS (1:10). After settling, the resulting supernatant was used for bacterial isolation. Serial dilutions of water and of the sediment supernatant in PBS were inoculated on chromID® CARBA SMART chromogenic culture media (BioMérieux) for screening CPE. Plates were incubated at 37°C for 48 h in aerobic conditions. The colonies obtained were identified by MALDI-TOF (VITEK MS, BioMérieux) and those identified as Enterobacteriaceae were selected for further analysis. Differentiation between Raoultella species (R. planticola and R. ornithinolytica) was carried out by PCR as described previously [17].
Antimicrobial susceptibility testing
Antimicrobial susceptibility to β-lactams of all the enterobacterial isolates recovered was studied by the disk diffusion method following EUCAST guidelines [18]. In addition, the MICs of meropenem, imipenem and ertapenem were determined by the Etest (BioMérieux) according to the manufacturer’s recommendations. Evidence suggestive of carbapenemase production was determined using EUCAST screening cut-off values (disk inhibition zones of <25 mm for meropenem and/or ertapenem, and/or <23 mm for imipenem; or MICs > 0.12 mg/L for meropenem and/or ertapenem and/or > 1 mg/L for imipenem).
Finally, the MIC of additional antimicrobials was also determined by the Etest in all the isolates. The compounds studied were: amoxicillin, amoxicillin/clavulanic acid, piperacillin/tazobactam, ceftazidime, cefotaxime, cefepime, cefoxitin, aztreonam, gentamicin, amikacin, nalidixic acid, ciprofloxacin, trimethoprim-sulfamethoxazole, fosfomycin and colistin. Interpretation of the results was performed according to the EUCAST clinical breakpoints when available [19]. Otherwise, CLSI breakpoints were used (e.g. cefoxitin and nalidixic acid) [20].
Detection of antimicrobial resistance genes, virulence genes and the phylogenetic group
All the isolates selected were screened by means of PCR and sequencing analysis to detect the presence of the following carbapenemase genes: blaOXA-48, blaVIM, blaKPC, blaNDM, blaIMI, blaIMP. In addition, carriage of further resistance genes such as those encoding ESBLs (blaTEM, blaSHV, blaCTX-M), plasmid-mediated AmpCs (blaDHA, blaAAC, blaACT, blaFOX, blaCMY), the blaOXA-1 gene, and plasmid-mediated quinolone resistance genes (aac(6’)-Ib-cr, qnrA, qnrB, qnrS) was also studied by PCR and sequencing. Individual amplifications (S1 Table) were performed with the exception of the plasmid-mediated ampC β-lactamase genes, which were assessed according to the previously described multiplex PCR [21]. Identification of the phylogenetic group (A, B1, B2, C, D, E or F) of the E. coli strains was similarly detected by PCR according to the most recent classification [22].
All E. coli strains were screened for the presence of 49 virulence factors (including 19 adhesins, 4 siderophores, 11 toxins, 6 capsule synthesis-associated genes, and 9 miscellaneous genes). Screening was performed by multiplex PCRs according to previously reported methodology [23]. In the case of K. pneumoniae, the presence of 9 virulence-associated genes was assessed by PCR. The set of factors included: the adhesin-encoding genes fimH (Type 1 fimbriae) and mrkD (Type 3 fimbriae), the capsule- and LPS-associated genes wabG and uge, the two genes magA and rmpA related to the mucoid phenotype, as well as other virulence-associated genes such as ureA (intestinal colonization), allS (liver infection) and kfuBC (iron uptake system) [24].
Clonal relatedness
Clonality of the E. coli isolates was analyzed by pulsed-field gel electrophoresis (PFGE) as described previously (http://www.cdc.gov/pulsenet/pdf/ecoli-shigella-salmonella-pfge-protocol-508c.pdf). Data were analyzed using GelCompar II v.4.6 (Applied Maths, SintMartens-Latem, Belgium). Requisites for strains to belong to the same pulsotype were to have a similarity criterion above 85%, with a position tolerance of 1% and an optimization of 1%.
Multilocus sequence typing (MLST) identification was carried out for E. coli, K. pneumoniae and E. cloacae by means of PCR and sequencing according to the protocols specified at the web sites http://mlst.ucc.ie/mlst/dbs/Ecoli, http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html and http://pubmlst.org/ecloacae, respectively.
Plasmid characterization
Identification of plasmid replicons was accomplished using the PCR-based replicon typing method as described previously [6,25,26]. The presence of PAS, according to previously reported methodology, was sought by PCR of 3 type I systems: Hok-Sok, PndA-PndC, SnrB-SnrC; and 5 type II systems: PemK-PemI, CcdA-CcdB, RelB-RelE, ParD-ParE, VagC-VagD [7]. The following genes encoding PPS were also determined by PCR: parAB, parMRC and sopAB. The primer sequences and annealing temperatures are shown in S1 Table.
Plasmid size was determined by PFGE of total DNA digested with S1 nuclease. Hybridization was then carried out to confirm all positive cases detected in the PCR screening. Specific DNA probes were obtained by PCR amplification with the same primers reported in S1 Table. The digoxigenin PCR DIG Probe Synthesis kit (Roche Diagnostics) was used to obtain digoxigenin-labeled probes. Hybridization and detection were performed according to the manufacturer’s instructions.
Transferability of the carbapenemase-containing plasmids (blaVIM-1, blaKPC-2, blaIMI-2) was attempted by conjugation at 37°C and 30°C using a kanamycin-resistant derivative of E. coli HB101 as recipient. Transconjugants were selected on Luria-Bertani (LB) agar plates supplemented with 300 μg/mL kanamycin and 200 μg/mL ampicillin. Transformations were then carried out for strains for which no transconjugant could be obtained. Plasmids were extracted by using the hot alkaline method [27] and were transformed by electroporation into electrocompetent E. coli HB101. Selection of transformants was done on LB agar plates containing 300 μg/mL kanamycin and 200 μg/mL ampicillin. Successful conjugation and transformation was confirmed by specific PCR amplification.
Results
Identification and characterization of carbapenem-resistant Enterobacteriaceae isolates
High density colonies grew on the CARBA SMART agar plates inoculated with the river and sediment samples. A total of 224 colonies were obtained: 50 from river water and 174 from sediment samples. However, only 8 (3.6%) isolates, all recovered from sediment samples, were found to be Enterobacteriaceae. The remaining isolates were: Pseudomonas putida (56%), Aeromonas spp. (26.5%), Pseudomonas fluorescens (7.5%), Pseudomonas chlororaphis (4%), Pseudomonas aeruginosa (3.5%), and other non-Enterobacteriaceae species (2.5%).
The molecular studies revealed that 5 isolates carried KPC-2 (3 E. coli, 1 K. pneumoniae, 1 Enterobacter cloacae), 1 strain was positive for VIM-1 (R. ornithinolytica) and 1 for IMI-2 (E. cloacae), whereas the remaining isolate (Klebsiella oxytoca) carried two carbapenemases: KPC-2 and VIM-1 (Table 1).
No strain was positive for the presence of additional β-lactam resistance determinants (i.e. ESBLs and plasmidic ampCs). Contrarily, up to 4 strains belonging to 4 different species were positive for the blaOXA-1 gene. Five strains were positive for the aminoglycoside acetyltransferase gene (2 carried the cr variant) and 3 for the presence of the qnrB gene (two qnrB6 and one qnrB5 variants) (Table 1). IMI-2-producing E. cloacae (3-CAR) was the only strain which was negative for the presence of any of the additional resistance genes evaluated.
All 3 E. coli strains belonged to different pulsotypes (data not shown) and different STs: ST1434 (1-CAR), ST216 (2-CAR) and the newly described ST5001 (4-CAR) (Table 1). Regarding the phylogenetic group, all 3 strains belonged to group A. The ST identified for the K. pneumoniae strain was ST634, whereas two new STs, ST822 and ST823, were assigned to the E. cloacae strains (3-CAR and 7-CAR, respectively).
Antimicrobial susceptibility profile of the strains
Susceptibility to the 18 antibiotics evaluated (11 β-lactams and 7 non-β-lactams) is shown in Table 2. All the isolates showed the expected hydrolytic profile according to the carbapenemase encoded whereas variable results were observed for the remaining antimicrobials (aminoglycosides, quinolones, trimethoprim-sulfamethoxazole and fosfomycin). Overall, all strains (100%) were resistant to amoxicillin, amoxicillin/clavulanic acid and ertapenem. Most strains (n = 7, 88%) were non-susceptible to piperacillin/tazobactam, ceftazidime, cefotaxime, cefepime, aztreonam and imipenem; followed by 5 strains (63%) non-susceptible to meropenem. Thus, ertapenem was the least active carbapenem (MIC50 of 24 μg/mL and MIC90 of 32 μg/ml) whereas meropenem and imipenem were slightly more active (MIC50 of 4 μg/mL and MIC90 of 32 μg/ml, and MIC50 of 4 μg/mL and MIC90 of 12 μg/ml, respectively).
Regarding non-β-lactam compounds, all strains (100%) were susceptible to gentamicin and colistin, 7 (88%) to amikacin and trimethoprim-sulfamethoxazole, whereas 5 strains (63%) were non-susceptible to ciprofloxacin and fosfomycin.
Detection of virulence genes
With respect to the analysis of the virulence-related genes, the three E. coli strains collected to study for presence of 49 virulence-related factors were only positive for the type I fimbrial adhesin fimH.
In the case of the K. pneumoniae strain, it was positive for the two fimbrial adhesin-encoding genes fimH (type I fimbriae) and mrkD (type 3 fimbriae), the two genes related to LPS and capsule biosynthesis wabG and uge, as well as ureA, the ureasa A subunit related to colonization.
Characteristics of the carbapenemase-encoding plasmids
Replicon typing analysis (Table 1) revealed that there was variability for the type of carbapenemase-encoding plasmids encountered in terms of incompatibility group and size. Specifically, for the 5 strains only positive for KPC-2, this resistance determinant was located in an IncN (70 kb), IncR (48 kb) or IncFIIK (97 kb) plasmids. In the case of the two VIM-1-producing microorganisms, this gene was carried in an IncR (70 kb) or IncN (60 kb) plasmids, being the latter also positive for KPC-2. Lastly, the results showed that the IMI-2-positive strain carried this resistance determinant in a larger, IncFIB plasmid (170 kb).
The analysis of PAS of the carbapenemase-encoding plasmids detected in the present study revealed that VagCD was the most prevalent system, being present in 4 (50%) strains (E. coli 1-CAR, R. ornithinolytica 5-CAR, K. pneumoniae 6-CAR, E. cloacae 7-CAR), followed by the ParDE (12.5%) and CcdAB (12.5%) systems which were codetected in the same strain (E. coli 4-CAR) (Table 1). On the contrary, three strains (E. coli 2-CAR, E. cloacae 3-CAR, K. oxytoca 8-CAR) were negative for the presence of all of the systems studied. The results obtained for the presence of PPS revealed that only two (25%) strains (E. coli 2-CAR, K. oxytoca 8-CAR), which were negative for PAS, carried the parAB genes. Only the IMI-2-producing E. cloacae (3-CAR) strain was negative for all the PAS and PPS evaluated. These results indicate that none of the plasmid-related stability systems studied here was associated with a particular carbapenem-resistance mechanism.
Regarding plasmid mobilization experiments, blaKPC-2-encoding transconjugants could be obtained from strains 1-CAR and 7-CAR. Additionally, a blaKPC-2-encoding tranformant was recovered from strain 4-CAR. The MICs for different antibiotics were evaluated for receptor and transconjugant/transformant strains and are shown in Table 2. Of note, the MICs of ERT and FOX were much lower in recipient strains than in donor strains. These changes might be due to the presence of chromosomally-encoded resistance mechanisms, as outer membrane permeability alterations, in the donor strains affecting the susceptibility to both antibiotics.
Discussion
The increasing rates of resistance to antimicrobial compounds that play a key role in the clinical setting, such as carbapenems, have led to an urgent need to understand the global spread of their resistance mechanisms. As a result, the role and impact of other ecological niches, such as rivers and hospital sewage systems, is of important concern, as is the detection of β-lactamases and other unrelated resistance mechanisms in these strains.
The CPE identified in the present work were only recovered from sediment samples. These results are in agreement with recent works which report increased load and longer persistence of bacteria inhabiting sediment samples in comparison with river water samples. Thereby these results suggest higher probability for detecting CPEs in sediment than river water [28]. Accordingly, the CPE isolated in this study were E. coli (3 strains, positive for KPC-2), K. pneumoniae (KPC-2-producer), K. oxytoca (KPC-2- and VIM-1-producer), E. cloacae (one positive for KPC-2 and one positive for IMI-2) and, lastly, R. ornithinolytica (VIM-1-producer). In terms of environmental epidemiology, the most prevalent microorganism producing KPC-2 is Klebsiella, followed by Enterobacter [5], albeit other microorganisms such as E. coli and Raoultella spp. have also been reported [5,29]. The VIM-1 enzyme has occasionally been detected in environmental samples and in a narrow spectrum of genera (e.g. K. pneumoniae [11] and E. coli [9]). There is only one previous identification in a R. ornithinolytica strain collected from fecal carriers in Spain [30] whereas, to our knowledge, this is the first identification of blaVIM-1 in this bacteria isolated from the environment. On the contrary, only three IMI-2 identifications have been documented so far: one Enterobacter asburiae (river sample, US) [10], one E. cloacae (clinical isolate, China) [14], and one E. coli (clinical isolate, Spain) [31]. Thus, this is also the first time that the IMI-2 determinant has been detected in bacteria of environmental origin in Europe.
Despite the increasing rates of carbapenem resistance in the clinical setting, it is rather infrequent to codetect several carbapenemases in the same strain. The most frequently identified microorganism is K. pneumoniae with a percentage estimated at 5.3% on considering carbapenemase-positive isolates in Greece, a carbapenemase endemic country [32]. In the present study we have codetected blaVIM-1 and blaKPC-2 in the same IncN plasmid in a K. oxytoca strain, being this the first case reported from an environmental strain.
In a multicenter study conducted in 2013 it was shown that the most prevalent carbapenemase in Enterobacteriaceae in Spain was OXA-48 (n = 271; 71%), followed by the VIM-type enzymes (n = 96; 25%), whereas the KPC family was uncommon (2%), and no isolate was an IMI-type producer [33]. Surprisingly, in the present study, in which the isolates were recovered only one year later, no OXA-48 was detected and VIM-type carbapenemases were represented at a lower frequency than KPC-type enzymes. Previous results available in the literature also describe a major prevalence of KPC and VIM determinants in the aquatic environment [3,9,12,29]; whereas, to our knowledge, no report has detected an OXA-48-producing CPE in the same type of samples.
The characterization of the virulence potential of the E. coli strains detected in this study revealed that they only were positive for fimH and belonged to the phylogenetic group A (usually associated with commensal strains that carry very few virulence factors). Three STs were identified in E. coli: i) ST1434, previously detected in Mexico in two strains recovered from water and human feces which were categorized as non-pathogenic [34]; ii) ST216, identified among ESBL-producing E. coli strains of fecal origin in the US [35] and Europe [36], and as the most prevalent ST in IMP-producing strains recovered from gulls feces in Australia [37]; and iii) ST5001, a singleton newly described in this study. Both ST1434 and ST216 belong to clonal complex CC10, from which several KPC-producing isolates have previously been described, although only in surveillance culture studies in Israel [38]. Concerning K. pneumoniae, even though strain 6-CAR possessed the most prevalent virulence factors reported in clinical isolates (fimH, mrkD, wabG, uge and ureA) [24], it was negative for the genes most significantly associated with invasive human infection (rmpA, fyuA, iutA, clbA-R, iroN) [39]. This strain belonged to ST634, a singleton for which no previous information could be found. Altogether, this information suggests that the virulence potential of the E. coli and K. pneumoniae isolates found in the present study may be considered of low risk. In the case of the two E. cloacae isolates, both belonged to STs of new description.
Plasmid addiction and partition systems have not been studied in depth when characterizing clinically-relevant plasmids. vagCD has been reported as the most represented PAS in clinical samples related to the spread of β-lactamases, followed by ccdAB, pemIK and hok-sok [40]. Concerning PPS, parAB has also been associated with carbapanemase-producing plasmids, as in the case of the widespread pOXA-48a plasmid in K. pneumoniae [41]. Similar results were detected in the present study: vagCD and parAB were the PAS and PPS, respectively, most frequently detected. These findings suggest that these systems deserve more attention and further research in order to clearly define their role in the successful dissemination of such plasmids.
Moreover, on integrating all the traits reported for the carbapenemase-producing plasmids found in the present work, most of the strains were shown to respectively harbor different plasmids. Nonetheless, the results obtained from the plasmid characterization suggest that the KPC-2-producing strains E. coli CAR-1 and E. cloacae CAR-7 may harbor the same plasmid (i.e, 70-kb IncN plasmid carrying the VagCD system as well as the blaOXA-1, aac(6’)-Ib and qnrB6 determinants). As these two strains belonged to different species, and taking into consideration the successful plasmid mobilization results for these two strains, it is easy to assume the occurrence of an in vivo environmental transference of this plasmid supporting its dissemination ability. This fact would provide means for this resistance determinant to eventually reach a human-adapted bacterial clone endangering the efficacy of the antimicrobial armamentarium.
Overall, the present study reports for the first time the presence of CPE recovered from a river ecosystem in the Barcelona metropolitan area. The results show that several species produce, and sometimes coproduce, different carbapenemases which are carried in different plasmids. No epidemiological relationship between these environmental isolates and the pathogenic strains detected in the clinical setting was found, hence suggesting that they might rather act as reservoirs. Surprisingly, KPC-2 was the most prevalent enzyme in contrast with the clinical situation in our country. These results reinforce the necessity to take into account all the diverse reservoirs encountered, including humans, animals and the environment, in the fight against antimicrobial resistance.
Author Contributions
- Conceptualization: JGL MM AF.
- Formal analysis: JGL AF NPC MM.
- Funding acquisition: JGL MM.
- Investigation: JGL AF NPC WCC TCS AMC MBJ MM.
- Methodology: JGL AF NPC WCC MM.
- Project administration: JGL MM AF.
- Resources: JGL MM.
- Supervision: JGL MM.
- Validation: JGL AF NPC WCC TCS AMC MBJ MM.
- Visualization: JGL AF NPC WCC MM.
- Writing – original draft: JGL AF NPC WCC MBJ MM.
- Writing – review & editing: JGL AF MM.
References
- 1. Hansen DS, Schumacher H, Hansen F, Stegger M, Hertz FB, Schønning K, et al. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence, β-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis. 2012;44: 174–181. pmid:22364227
- 2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention. Clin Infect Dis. 2011;53: 60–67. pmid:21653305
- 3. Woodford N, Wareham DW, Guerra B, Teale C. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making? J Antimicrob Chemother. 2014;69: 287–291. pmid:24092657
- 4. Gudeta DD, Bortolaia V, Jayol A, Poirel L, Nordmann P, Guardabassi L. Chromobacterium spp. harbour Ambler class A β-lactamases showing high identity with KPC. J Antimicrob Chemother. 2016; dkw020.
- 5. Picão RC, Cardoso JP, Campana EH, Nicoletti AG, Petrolini FVB, Assis DM, et al. The route of antimicrobial resistance from the hospital effluent to the environment: focus on the occurrence of KPC-producing Aeromonas spp. and Enterobacteriaceae in sewage. Diagn Microbiol Infect Dis. 2013;76: 80–85. pmid:23478032
- 6. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63: 219–228. pmid:15935499
- 7. Mnif B, Vimont S, Boyd A, Bourit E, Picard B, Branger C, et al. Molecular characterization of addiction systems of plasmids encoding extended-spectrum -lactamases in Escherichia coli. J Antimicrob Chemother. 2010;65: 1599–1603. pmid:20507859
- 8. Baxter JC, Funnell BE. Plasmid Partition Mechanisms. Microbiol Spectr. 2014;2: PLAS–0023.
- 9. Kieffer N, Poirel L, Bessa LJ, Barbosa-Vasconcelos A, da Costa PM, Nordmann P. VIM-1, VIM-34, and IMP-8 Carbapenemase-Producing Escherichia coli Strains Recovered from a Portuguese River. Antimicrob Agents Chemother. 2016;60: 2585–2586. pmid:26810648
- 10. Aubron C, Poirel L, Ash RJ, Nordmann P. Carbapenemase-producing Enterobacteriaceae, US rivers. Emerg Infect Dis. 2005;11: 260–4. pmid:15752444
- 11. Chouchani C, Marrakchi R, Henriques I, Correia A. Occurrence of IMP-8, IMP-10, and IMP-13 metallo-β-lactamases located on class 1 integrons and other extended-spectrum β-lactamases in bacterial isolates from Tunisian rivers. Scand J Infect Dis. 2013;45: 95–103. pmid:22992193
- 12. Akiba M, Sekizuka T, Yamashita A, Kuroda M, Fujii Y, Murata M, et al. Distribution and Relationships of Antimicrobial Resistance Determinants among Extended-Spectrum-Cephalosporin-Resistant or Carbapenem-Resistant Escherichia coli Isolates from Rivers and Sewage Treatment Plants in India. Antimicrob Agents Chemother. 2016;60: 2972–2980. pmid:26953207
- 13. Zhang X, Lü X, Zong Z. Enterobacteriaceae producing the KPC-2 carbapenemase from hospital sewage. Diagn Microbiol Infect Dis. 2012;73: 204–206. pmid:22463869
- 14. Yu Y-S, Du X-X, Zhou Z-H, Chen Y-G, Li L-J. First Isolation of blaIMI-2 in an Enterobacter cloacae Clinical Isolate from China. Antimicrob Agents Chemother. 2006;50: 1610–1611. pmid:16569898
- 15. Muniesa M, Lucena F, Blanch AR, Payán A, Jofre J. Use of abundance ratios of somatic coliphages and bacteriophages of Bacteroides thetaiotaomicron GA17 for microbial source identification. Water Res. 2012;46: 6410–6418. pmid:23039916
- 16. Sabater S, Muñoz I, García-Berthou E, Barceló D. Multiple stressors in Mediterranean freshwater ecosystems: The Llobregat River as a paradigm. Contributions to Science. 2015. pp. 161–169.
- 17. Walckenaer E, Leflon-Guibout V, Nicolas-Chanoine M-H. How to identify Raoultella spp. including R. ornithinolytica isolates negative for ornithine decarboxylase? The reliability of the chromosomal bla gene. J Microbiol Methods. 2008;75: 405–410. pmid:18694786
- 18. Matuschek E, Brown DFJ, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20: O255–O266. pmid:24131428
- 19.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. 2016;Version 6.0 EUCAST: Available from: http://www.eucast.org/clinical–breakpoints/.
- 20.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI Supplement M100S. Wayne, Pennsylvania 19087 USA; 2016.
- 21. Perez-Perez FJ, Hanson ND. Detection of Plasmid-Mediated AmpC -Lactamase Genes in Clinical Isolates by Using Multiplex PCR. J Clin Microbiol. 2002;40: 2153–2162. pmid:12037080
- 22. Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo‐typing method revisited: improvement of specificity and detection of new phylo‐groups. Environ Microbiol Rep. 2013;5: 58–65. pmid:23757131
- 23. Oteo J, Gonzalez-Lopez JJ, Ortega A, Quintero-Zarate JN, Bou G, Cercenado E, et al. Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical Isolates. Antimicrob Agents Chemother. 2014;58: 3874–3881. pmid:24777096
- 24. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, et al. Virulent Clones of Klebsiella pneumoniae: Identification and Evolutionary Scenario Based on Genomic and Phenotypic Characterization. Neyrolles O, editor. PLoS ONE. 2009;4: e4982. pmid:19319196
- 25. Carattoli A, Seiffert SN, Schwendener S, Perreten V, Endimiani A. Differentiation of IncL and IncM plasmids associated with the spread of clinically relevant antimicrobial resistance. PloS One. 2015;10: e0123063. pmid:25933288
- 26. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother. 2010;65: 2518–2529. pmid:20935300
- 27. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol. 1981;145: 1365–1373. pmid:7009583
- 28. Calero-Cáceres W, Méndez J, Martín-Díaz J, Muniesa M. The occurrence of antibiotic resistance genes in a Mediterranean river and their persistence in the riverbed sediment. Environ Pollut Barking Essex 1987. 2017;
- 29. Poirel L, Barbosa-Vasconcelos A, Simoes RR, Da Costa PM, Liu W, Nordmann P. Environmental KPC-Producing Escherichia coli Isolates in Portugal. Antimicrob Agents Chemother. 2012;56: 1662–1663. pmid:22203588
- 30. Ruiz-Garbajosa P, Hernández-García M, Beatobe L, Tato M, Méndez MI, Grandal M, et al. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2016;71: 348–352. pmid:26518051
- 31. Rojo-Bezares B, Martin C, Lopez M, Torres C, Saenz Y. First Detection of blaIMI-2 Gene in a Clinical Escherichia coli Strain. Antimicrob Agents Chemother. 2012;56: 1146–1147. pmid:22106212
- 32. Papagiannitsis CC, Tryfinopoulou K, Giakkoupi P, Pappa O, Tzelepi E, Leonidas S T. Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals. Int J Antimicrob Agents. 2012;39: 178–180. pmid:22104281
- 33. Oteo J, Ortega A, Bartolomé R, Bou G, Conejo C, Fernández-Martínez M, et al. Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals High In Vitro Susceptibility to Colistin and Meropenem. Antimicrob Agents Chemother. 2015;59: 3406–3412. pmid:25824224
- 34. González-González A, Sánchez-Reyes LL, Delgado Sapien G, Eguiarte LE, Souza V. Hierarchical clustering of genetic diversity associated to different levels of mutation and recombination in Escherichia coli: A study based on Mexican isolates. Infect Genet Evol. 2013;13: 187–197. pmid:22995280
- 35. Hazen TH, Zhao L, Boutin MA, Stancil A, Robinson G, Harris AD, et al. Comparative Genomics of an IncA/C Multidrug Resistance Plasmid from Escherichia coli and Klebsiella Isolates from Intensive Care Unit Patients and the Utility of Whole-Genome Sequencing in Health Care Settings. Antimicrob Agents Chemother. 2014;58: 4814–4825. pmid:24914121
- 36. Adler A, Baraniak A, Izdebski R, Fiett J, Salvia A, Samso JV, et al. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres. Clin Microbiol Infect. 2014;20: O516–O523. pmid:24450778
- 37. Dolejska M, Masarikova M, Dobiasova H, Jamborova I, Karpiskova R, Havlicek M, et al. High prevalence of Salmonella and IMP-4-producing Enterobacteriaceae in the silver gull on Five Islands, Australia. J Antimicrob Chemother. 2016;71: 63–70. pmid:26472769
- 38. Adler A, Miller-Roll T, Assous MV, Geffen Y, Paikin S, Schwartz D, et al. A multicenter study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel. Clin Microbiol Infect. 2015;21: 230–235. pmid:25658543
- 39. Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci. 2015;112: E3574–E3581. pmid:26100894
- 40. Mnif B, Harhour H, Jdidi J, Mahjoubi F, Genel N, Arlet G, et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems. BMC Microbiol. 2013;13: 1.
- 41. Poirel L, Bonnin RA, Nordmann P. Genetic Features of the Widespread Plasmid Coding for the Carbapenemase OXA-48. Antimicrob Agents Chemother. 2012;56: 559–562. pmid:22083465